Anika Therapeutics Inc - Common Stock (ANIK)

CUSIP: 035255108

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
13,404,566
Total 13F shares
12,231,336
Share change
-467,760
Total reported value
$114,982,408
Price per share
$9.40
Number of holders
114
Value change
-$5,970,888
Number of buys
68
Number of sells
38

Security key

035255108

Report period

Q3 2025

Institutions

114

Top holders

10

Top shareholders of ANIK - Anika Therapeutics Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Trigran Investments, Inc.
13F
Company
15%
2,036,511
$21,546,286 30 Jun 2025
13F
BlackRock, Inc.
13F 13D/G
Company
6.8%
from 13D/G
1,528,286
$16,169,267 30 Jun 2025
Caligan Partners LP
13F
Company
11%
1,435,130
$15,183,675 30 Jun 2025
13F
DIMENSIONAL FUND ADVISORS LP
13D/G 13F
Company
4.5%
657,355
$9,656,545 $0 31 Dec 2024
VANGUARD GROUP INC
13F
Company
5.8%
779,473
$8,246,824 30 Jun 2025
13F
BlackRock Portfolio Management LLC
13D/G
5.5%
793,359
$7,454,957 $0 30 Sep 2025
Opaleye Management Inc.
13F
Company
4.4%
588,797
$6,229,472 30 Jun 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
4.3%
575,644
$6,084,000 30 Jun 2025
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
4%
529,503
$5,602,142 30 Jun 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
3.9%
527,217
$5,577,956 30 Jun 2025
13F
Alta Fundamental Advisers LLC
13F
Company
3.4%
454,944
$4,813,308 30 Jun 2025
13F
CAPITAL MANAGEMENT CORP /VA
13F
Company
3.1%
408,845
$4,325,580 30 Jun 2025
13F
STATE STREET CORP
13F
Company
2.4%
324,361
$3,431,739 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.4%
321,211
$3,399,449 30 Jun 2025
13F
Stonepine Capital Management, LLC
13F
Company
1.4%
190,590
$2,016,442 30 Jun 2025
13F
Michael L. Levitz
3/4/5
EVP, CFO, Treasurer
mixed-class rows
119,966
mixed-class rows
$1,761,044 15 Mar 2024
MILLENNIUM MANAGEMENT LLC
13F
Company
1%
133,673
$1,414,260 30 Jun 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.99%
133,047
$1,407,637 30 Jun 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
0.93%
124,079
$1,312,756 30 Jun 2025
13F
ENVESTNET ASSET MANAGEMENT INC
13F
Company
0.91%
121,387
$1,284,274 30 Jun 2025
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.89%
119,338
$1,262,596 30 Jun 2025
13F
NORTHERN TRUST CORP
13F
Company
0.86%
114,631
$1,212,796 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.81%
108,382
$1,146,683 30 Jun 2025
13F
UBS Group AG
13F
Company
0.68%
91,067
$963,489 30 Jun 2025
13F
GLOBEFLEX CAPITAL L P
13F
Company
0.65%
87,600
$926,808 30 Jun 2025
13F
DEUTSCHE BANK AG\
13F
Company
0.61%
81,290
$860,048 30 Jun 2025
13F
Cove Street Capital, LLC
13F
Company
0.55%
74,099
$783,967 30 Jun 2025
13F
Anne Nunes
3/4/5
SVP, Chief Operations Officer
mixed-class rows
65,283
mixed-class rows
$725,770 14 Mar 2025
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.48%
64,872
$686,346 30 Jun 2025
13F
DIKER MANAGEMENT LLC
13F
Company
0.42%
56,839
$601,357 30 Jun 2025
13F
Thomas Finnerty
3/4/5
EVP, Human Resources
mixed-class rows
29,695
mixed-class rows
$589,713 09 Mar 2022
Jeffery S. Thompson
3/4/5
Director
class O/S missing
31,575
$588,242 14 Jun 2023
Glenn R. Larsen
3/4/5
Director
0.37%
50,258
$564,899 20 Jun 2025
Susan L. N. Vogt
3/4/5
Director
0.37%
50,213
$564,394 20 Jun 2025
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.4%
52,994
$560,677 30 Jun 2025
13F
Stephen Richard
3/4/5
Director
0.36%
47,871
$538,070 20 Jun 2025
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.38%
50,814
$537,612 30 Jun 2025
13F
Bank of New York Mellon Corp
13F
Company
0.35%
47,031
$497,586 30 Jun 2025
13F
Sheryl L. Conley
3/4/5
Director
0.32%
42,568
$478,464 20 Jun 2025
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.33%
44,761
$473,571 30 Jun 2025
13F
Gary P. Fischetti
3/4/5
Director
0.31%
41,613
$467,730 20 Jun 2025
AMERICAN CENTURY COMPANIES INC
13F
Company
0.33%
44,161
$467,223 30 Jun 2025
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.32%
42,994
$454,877 30 Jun 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.31%
41,362
$437,609 30 Jun 2025
13F
BARCLAYS PLC
13F
Company
0.26%
35,390
$374,427 30 Jun 2025
13F
Fisher Asset Management, LLC
13F
Company
0.26%
34,494
$364,946 30 Jun 2025
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.24%
32,427
$343,078 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.23%
30,862
$326,520 30 Jun 2025
13F
Nuveen, LLC
13F
Company
0.23%
30,372
$321,336 30 Jun 2025
13F
Cerity Partners LLC
13F
Company
0.22%
29,867
$315,992 30 Jun 2025
13F

Institutional Holders of Anika Therapeutics Inc - Common Stock (ANIK) as of Q3 2025

As of 30 Sep 2025, Anika Therapeutics Inc - Common Stock (ANIK) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,231,336 shares. The largest 10 holders included BlackRock, Inc., Trigran Investments, Inc., Caligan Partners LP, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, CAPITAL MANAGEMENT CORP /VA, BOOTHBAY FUND MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, and MORGAN STANLEY. This page lists 114 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
101
Q3 2025 holders
114
Holder diff
13
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .